Topological aspects of oligomeric UDP-glucuronosyltransferases in endoplasmic reticulum membranes: advances and open questions

Biochemical Pharmacology
Karl Walter Bock, Christoph Köhle

Abstract

UDP-glucuronosyltransferases (UGTs) represent major Phase II enzymes involved in detoxification of endo- and xenobiotics, including many drugs. The intraluminal orientation of the active site of UGTs in endoplasmic reticulum membranes necessitates a number of transporters in these membranes, for example, for UDP-glucuronic acid and glucuronides, the latter being insufficiently characterized. In addition, accumulating evidence suggests that UGTs are functional as homo- and heterodimers in monoglucuronide formation. They may form tetramers in diglucuronide formation. UGT oligomers probably serve to stabilize UGT monomers and fine-tune UGT activity. Glucuronide disposition may also be influenced by endoplasmic reticulum-localized beta-glucuronidase, possibly involved in hydrolysis of hormone and drug glucuronides in target cells. The present commentary reviews recent advances and addresses open questions. Resolution of these questions may help to understand many problems of glucuronide synthesis and disposition in vivo, for example, under-prediction of the in vivo clearance of drugs mostly eliminated by glucuronidation by in vitro enzyme kinetic parameters of UGTs.

References

Jul 1, 1981·Archives of Biochemistry and Biophysics·R H Tukey, T R Tephly
Jul 1, 1993·Trends in Biochemical Sciences·E S Kempner
Oct 27, 1997·The Journal of Biological Chemistry·R Meech, P I Mackenzie
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·E BeutlerA Demina
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·R H Tukey, C P Strassburg
Mar 22, 2002·The Journal of Pharmacology and Experimental Therapeutics·M G SoarsR J Riley
Aug 16, 2002·Molecular Pharmacology·Robert H TukeyPeter I Mackenzie
Nov 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·David E BarananoSolomon H Snyder
Dec 18, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Soundararajan KrishnaswamyMichael H Court
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·John O MinersPeter I Mackenzie
Feb 12, 2004·Cancer Research·Yannick DuguayImmaculata De Vivo
Sep 4, 2004·Biochemical Pharmacology·Miklós CsalaBrian Burchell
Sep 6, 2005·Pharmacogenetics and Genomics·Peter I MackenzieDaniel W Nebert
Nov 25, 2005·European Journal of Clinical Pharmacology·M Strolin BenedettiF Tonner
Jan 10, 2006·Methods in Enzymology·Karl Walter Bock, Christoph Köhle
Mar 10, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Jörg KönigMartin F Fromm
Jul 11, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ryoichi FujiwaraTsuyoshi Yokoi
Jul 12, 2007·Pharmacogenetics and Genomics·Andrea L Yoder GraberMark J Ratain
Nov 14, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ryoichi FujiwaraTsuyoshi Yokoi

❮ Previous
Next ❯

Citations

Dec 17, 2009·Antioxidants & Redox Signaling·Miklós CsalaGábor Bánhegyi
Jun 29, 2010·Cancer Biotherapy & Radiopharmaceuticals·Ilker Emin MedineFeriha Toksöz
Jun 20, 2013·Rejuvenation Research·Huma NazImtaiyaz Hassan
May 12, 2011·Drug Metabolism and Drug Interactions·Marisol LópezAdrián Llerena
Mar 24, 2015·Expert Opinion on Drug Metabolism & Toxicology·Zoe Riches, Abby C Collier
Oct 8, 2009·Drug Metabolism Reviews·Jacques MagdalouMohamed Ouzzine
Oct 13, 2009·Drug Metabolism Reviews·Yuji IshiiHideyuki Yamada
Jul 6, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Florent Di MeoPatrick Trouillas
Mar 16, 2018·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·So-Young KimGrover P Miller
Sep 23, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tina Trdan LusinAles Mrhar
Dec 17, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Călin-Aurel DrăganMatthias Bureik
Jul 9, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Judith BellemareChantal Guillemette

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.